These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36525355)

  • 21. New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes.
    Cotovio P; Neves M; Rodrigues L; Alves R; Bastos M; Baptista C; Macário F; Mota A
    Transplant Proc; 2013 Apr; 45(3):1079-83. PubMed ID: 23622631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New-onset diabetes and nephropathy after renal transplantation.
    Guitard J; Rostaing L; Kamar N
    Contrib Nephrol; 2011; 170():247-255. PubMed ID: 21659777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
    Rathi M; Rajkumar V; Rao N; Sharma A; Kumar S; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New-onset Diabetes Mellitus After Kidney Transplantation-A Paired Kidney Analysis.
    Bzoma B; Konopa J; Chamienia A; Łukiański M; Kobiela J; Śledziński Z; Dębska-Ślizień A
    Transplant Proc; 2018; 50(6):1781-1785. PubMed ID: 30056900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study.
    Yu H; Kim H; Baek CH; Baek SD; Jeung S; Han DJ; Park SK
    BMC Nephrol; 2016 Jul; 17(1):106. PubMed ID: 27473469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.
    Shi D; Xie T; Deng J; Niu P; Wu W
    Eur J Clin Pharmacol; 2018 Jun; 74(6):723-729. PubMed ID: 29546446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of metabolic syndrome with development of new-onset diabetes after transplantation.
    Bayer ND; Cochetti PT; Anil Kumar MS; Teal V; Huan Y; Doria C; Bloom RD; Rosas SE
    Transplantation; 2010 Oct; 90(8):861-6. PubMed ID: 20724958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.
    Gaynor JJ; Ciancio G; Guerra G; Sageshima J; Hanson L; Roth D; Goldstein MJ; Chen L; Kupin W; Mattiazzi A; Tueros L; Flores S; Barba LJ; Lopez A; Rivas J; Ruiz P; Vianna R; Burke GW
    Diabetologia; 2015 Feb; 58(2):334-45. PubMed ID: 25361829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients.
    Hayes W; Boyle S; Carroll A; Bockenhauer D; Marks SD
    Pediatr Nephrol; 2017 May; 32(5):879-884. PubMed ID: 28039534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
    Ghisdal L; Bouchta NB; Broeders N; Crenier L; Hoang AD; Abramowicz D; Wissing KM
    Transpl Int; 2008 Feb; 21(2):146-51. PubMed ID: 17971033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.
    Zolota A; Miserlis G; Solonaki F; Tranda A; Antoniadis N; Imvrios G; Fouzas I
    Transplant Proc; 2018 Dec; 50(10):3386-3391. PubMed ID: 30577210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
    Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
    Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
    Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria.
    Rodrigo E; Santos L; Piñera C; Quintanar JA; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; Arias M
    Transplant Proc; 2011; 43(6):2208-10. PubMed ID: 21839235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretransplant Homeostasis Model Assessment of Insulin Resistance and Fasting Plasma Glucose Predict New-Onset Diabetes After Renal Transplant in Chinese Patients.
    Cai R; Wu M; Lin M; Guo X; Xing Y
    Transplant Proc; 2019 Apr; 51(3):768-773. PubMed ID: 30979462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?
    Prasad N; Gurjer D; Bhadauria D; Gupta A; Srivastava A; Kaul A; Jaiswal A; Yadav B; Yadav S; Sharma RK
    Nephrology (Carlton); 2014 Apr; 19(4):244-50. PubMed ID: 24447227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
    Tillmann FP; Schmitz M; Rump LC; Quack I
    Int Urol Nephrol; 2018 Apr; 50(4):771-777. PubMed ID: 29197933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and management of new-onset diabetes mellitus in kidney transplantation.
    Juan Khong M; Ping Chong Ch
    Neth J Med; 2014 Apr; 72(3):127-34. PubMed ID: 24846925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new-onset diabetes after kidney transplantation.
    Liang J; Lv C; Chen M; Xu M; Zhao C; Yang Y; Wang J; Zhu D; Gao J; Rong R; Zhu T; Yu M
    J Diabetes; 2019 May; 11(5):370-378. PubMed ID: 30203544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.